Current:Home > MarketsMalaria mass-vaccination program launches in Cameroon, bringing hope as Africa battles surging infections-LoTradeCoin
Malaria mass-vaccination program launches in Cameroon, bringing hope as Africa battles surging infections
View Date:2024-12-23 23:58:52
Johannesburg — It seems hard to believe that Africa's biggest killer is a tiny insect, but almost every minute, an African child dies with malaria. The continent bears the brunt of the mosquito-borne disease, with 95% of the fatal cases recorded every year, and children under the age of 5 make up about 80% of those deaths.
The malaria parasite spreads to people bitten by infected mosquitos, and causes initial symptoms including high fever, headache and chills.
But finally, after four decades in the making, there's hope for the widespread prevention of malaria infections across Africa as a new vaccine is rolled out across the continent.
History was made Monday in Cameroon as the first routine vaccination program against the mosquito-borne illness got underway. Cameroon hoped to vaccinate roughly 250,000 children over the next two years.
"The arrival of the vaccines marks a historic step in our efforts to control malaria, which remains a major public health threat in the country," said Dr. Malachie Manaouda, Cameroon's Minister of Public Health.
"We have been waiting for a day like this," Mohammed Abdulaziz, the head of disease control and prevention at the Africa CDC, told journalists at a news conference to mark the launch. "We are not just witnessing history, but actively participating in a transformative chapter in Africa public health history. It brings more than just hope — a reduction in the mortality and morbidity associated with malaria."
The RTS,S/AS01 vaccine, also known as Mosquirix, was developed by British pharmaceuticals giant GlaxoSmithKline in conjunction with the Path Malaria Vaccine Initiative. It was recommended for use in such widespread fashion by the World Heath Organization in 2021, and is being rolled out in 19 countries in addition to Cameroon after having undergone successful trials in Ghana and Kenya.
The plan is for some 30 million doses of the vaccine to be administered in the coming months across all participating nations.
According to the WHO, malaria cases were up by almost 5 million in 2022 compared to the previous year. The increase in infections has been attributed largely to rising resistance to insecticides in the mosquitoes that carry the parasite, along with disruptions in health care and supply chains caused by the COVID-19 pandemic.
The WHO recommends a four-dose plan for children around five months of age, with a fifth dose in high-risk areas. The trials showed that vaccinating kids before the rainy season, while also administering anti-malarial drugs, cut deaths by nearly two-thirds.
Two million children in Ghana, Kenya and Malawi have already been vaccinated in a pilot program, and the WHO said studies of those children showed a 30% reduction in severe malaria symptoms.
A second vaccine, R21, developed by Oxford University and produced by the Serum Institute of India, completed a final regulatory step in December and is expected to be distributed in seven countries beginning in May or June. That vaccine's approval reassured health officials on the continent amid concerns that the eagerness of nations to participate in the program could lead to shortages.
Both vaccines, in trials, prevented half of malaria cases in the year after vaccination. Neither vaccine stops transmission of the disease.
The rollout will face challenges in many of the countries about to get the vaccine, as they struggle with transport and other infrastructure hurdles, leading those in charge of the program to suggest that local health workers schedule malaria vaccine shots in conjunction with other vaccinations, such as measles.
Health officials have warned the Ministries of Health in the initial 20 countries that the success of the vaccines will also depend on local health officials' level of preparation, including the continued provision and use of bed nets and spraying of insecticides.
Ten other countries have expressed an interest in the vaccine already, and officials involved expect that number to increase.
- In:
- Centers for Disease Control and Prevention
- malaria
- Vaccine
- Africa
veryGood! (1566)
Related
- Who is Rep. Matt Gaetz, the Florida congressman Donald Trump picked to serve as attorney general?
- Venice becomes first city in the world to charge day trippers a tourist fee to enter
- Provost at Missouri university appointed new Indiana State University president, school says
- Chasing ‘Twisters’ and collaborating with ‘tornado fanatic’ Steven Spielberg
- Record-setting dry conditions threaten more US wildfires, drinking water supplies
- Tennessee governor signs bills to allow armed teachers nearly a year after deadly Nashville shooting
- Candace Cameron Bure Shares Advice for Child Actors After Watching Quiet on Set
- JPMorgan’s Dimon says stagflation is possible outcome for US economy, but he hopes for soft landing
- RHOBH's Kyle Richards Shares Reaction to BFF Teddi Mellencamp's Divorce
- They say don’t leave valuables in parked cars in San Francisco. Rep. Adam Schiff didn’t listen
Ranking
- Brands Our Editors Are Thankful For in 2024
- At least 15 people died in Texas after medics injected sedatives during encounters with police
- Rebel Wilson's memoir allegation against Sacha Baron Cohen redacted in UK edition: Reports
- Windmill sails mysteriously fall off Paris' iconic Moulin Rouge cabaret: It's sad
- Georgia remains part of College Football Playoff bracket projection despite loss
- Berkshire Hathaway’s real estate firm to pay $250 million to settle real estate commission lawsuits
- Provost at Missouri university appointed new Indiana State University president, school says
- Murder Victim Margo Compton’s Audio Diaries Revealed in Secrets of the Hells Angels Docuseries
Recommendation
-
2 more escaped monkeys recaptured and enjoying peanut butter and jelly sandwiches in South Carolina
-
Lakers' 11th loss in a row to Nuggets leaves them on brink of playoff elimination
-
Takeaways from AP’s investigation into fatal police encounters involving injections of sedatives
-
Joel Embiid scores 50 points to lead 76ers past Knicks 125-114 to cut deficit to 2-1
-
Anti-abortion advocates press Trump for more restrictions as abortion pill sales spike
-
Venice becomes first city in the world to charge day trippers a tourist fee to enter
-
Michigan man charged with manslaughter in deadly building explosion
-
Philadelphia 76ers' Joel Embiid says he's being treated for Bell's palsy